Complete Genome Sequencing of Acinetobacter baumannii Strain K50 Discloses the Large Conjugative Plasmid pK50a Encoding Carbapenemase OXA-23 and Extended-Spectrum β-Lactamase GES-11

Antimicrobial Agents and Chemotherapy
Daniel WibbergAndreas Schlüter

Abstract

Multidrug-resistant (MDR) Acinetobacter baumannii strains appeared as serious emerging nosocomial pathogens in clinical environments and especially in intensive care units (ICUs). A. baumannii strain K50, recovered from a hospitalized patient in Kuwait, exhibited resistance to carbapenems and additionally to ciprofloxacin, chloramphenicol, sulfonamides, amikacin, and gentamicin. Genome sequencing revealed that the strain possesses two plasmids, pK50a (79.6 kb) and pK50b (9.5 kb), and a 3.75-Mb chromosome. A. baumannii K50 exhibits an average nucleotide identity (ANI) of 99.98% to the previously reported Iraqi clinical isolate AA-014, even though the latter strain lacked plasmid pK50a. Strain K50 belongs to sequence type 158 (ST158) (Pasteur scheme) and ST499 (Oxford scheme). Plasmid pK50a is a member of the Aci6 (replication group 6 [RG6]) group of Acinetobacter plasmids and carries a conjugative transfer module and two antibiotic resistance gene regions. The transposon Tn2008 carries the carbapenemase gene blaOXA-23, whereas a class 1 integron harbors the resistance genes blaGES-11, aacA4, dfrA7, qacEΔ1, and sul1, conferring resistance to all β-lactams and reduced susceptibility to carbapenems and resistance to aminoglycosides...Continue Reading

References

Apr 12, 2003·Nucleic Acids Research·Folker MeyerAlfred Pühler
Feb 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Konstantinos T Konstantinidis, James M Tiedje
Apr 25, 2006·FEMS Microbiology Letters·Jane F TurtonTyrone L Pitt
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa L Maragakis, Trish M Perl
Jun 20, 2008·Cellular Microbiology·Carlos J RosadoMichelle A Dunstone
Oct 22, 2008·Journal of Bacteriology·Mark D AdamsSteven R Gill
Apr 28, 2009·FEMS Microbiology Reviews·María Pilar Garcillán-BarciaFernando de la Cruz
May 20, 2009·Antimicrobial Agents and Chemotherapy·Carole MoubareckThierry Lambert
Dec 18, 2009·Bioinformatics·Peter Husemann, Jens Stoye
Apr 9, 2010·The Journal of Antimicrobial Chemotherapy·Virginia PostRuth M Hall
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Alessia BertiniAlessandra Carattoli
Sep 2, 2010·Antimicrobial Agents and Chemotherapy·Pierre BogaertsYouri Glupczynski
Mar 15, 2011·Journal of Bacteriology·Chun-Chen ChenShu-Ying Li
Aug 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Evan S SnitkinJulie A Segre
Oct 12, 2011·BMC Microbiology·Pier Paolo Di NoceraRaffaele Zarrilli
Oct 24, 2012·Antimicrobial Agents and Chemotherapy·Rémy A BonninLaurent Poirel
Jan 15, 2013·Journal of Bacteriology·Matthew D NortonVeronica G Godoy
Mar 26, 2013·PloS One·Daniel N FarrugiaIan T Paulsen
Apr 4, 2013·Mobile Genetic Elements·Sara DominguesKaare M Nielsen
Jun 5, 2013·Mobile Genetic Elements·Maria Pilar Garcillán-Barcia, Fernando de la Cruz
Oct 23, 2013·Antimicrobial Agents and Chemotherapy·Sushim Kumar GuptaJean-Marc Rolain
Nov 22, 2013·The Journal of Antimicrobial Chemotherapy·Arzu Nazli ZekaPatrice Nordmann
Jan 1, 2014·Pathogens and Disease·Luísa C S AntunesKevin J Towner
Mar 20, 2014·Bioinformatics·Torsten Seemann
May 23, 2014·Microbiology and Molecular Biology Reviews : MMBR·Michael R Gillings

❮ Previous
Next ❯

Citations

Apr 6, 2019·Microbiology Resource Announcements·Masoumeh MadhiRikke H Olsen
Jul 14, 2020·World Journal of Microbiology & Biotechnology·Marco A BrovedanGuillermo D Repizo
Jan 17, 2020·Annals of Clinical Microbiology and Antimicrobials·Nabil KarahIrfan Ahmad
Jul 7, 2020·Frontiers in Microbiology·Abraham D Salgado-CamargoMiguel A Cevallos
Apr 2, 2021·Frontiers in Medicine·Melise Chaves SilveiraAna Paula D'Alincourt Carvalho-Assef

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.